Li Shuang-xi, Li Juan, Bian Qi, Dong Rui, Sun Jing, Guo Zhi-yong, Xu Jing. Rituximab as a front-line therapy for minimal change disease: one case report[J]. Journal of Clinical Nephrology, 2023, 23(1): 82-85. DOI: 10.3969/j.issn.1671-2390.2023.01.015
|
Citation:
|
Li Shuang-xi, Li Juan, Bian Qi, Dong Rui, Sun Jing, Guo Zhi-yong, Xu Jing. Rituximab as a front-line therapy for minimal change disease: one case report[J]. Journal of Clinical Nephrology, 2023, 23(1): 82-85. DOI: 10.3969/j.issn.1671-2390.2023.01.015
|
Li Shuang-xi, Li Juan, Bian Qi, Dong Rui, Sun Jing, Guo Zhi-yong, Xu Jing. Rituximab as a front-line therapy for minimal change disease: one case report[J]. Journal of Clinical Nephrology, 2023, 23(1): 82-85. DOI: 10.3969/j.issn.1671-2390.2023.01.015
|
Citation:
|
Li Shuang-xi, Li Juan, Bian Qi, Dong Rui, Sun Jing, Guo Zhi-yong, Xu Jing. Rituximab as a front-line therapy for minimal change disease: one case report[J]. Journal of Clinical Nephrology, 2023, 23(1): 82-85. DOI: 10.3969/j.issn.1671-2390.2023.01.015
|
.png)
DownLoad: